Simultaneously, myostatin, via decreasing adiponectin, damaging insulin signaling, and fat oxidation, could result in the accumulation of fat mass and thus do harm to NAFLD as well [12, 52]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.